Cargando…

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer

Anti–epidermal growth factor receptor (EGFR) antibodies are effective treatments for metastatic colorectal cancer. Improved understanding of acquired resistance mechanisms may facilitate circulating tumor DNA (ctDNA) monitoring, anti-EGFR rechallenge, and combinatorial strategies to delay resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topham, James T., O'Callaghan, Chris J., Feilotter, Harriet, Kennecke, Hagen F., Lee, Young S., Li, Weimin, Banks, Kimberly C., Quinn, Katie, Renouf, Daniel J., Jonker, Derek J., Tu, Dongsheng, Chen, Eric X., Loree, Jonathan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870216/ https://www.ncbi.nlm.nih.gov/pubmed/36007218 http://dx.doi.org/10.1200/JCO.22.00364

Ejemplares similares

Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
por: Boutin, Mélina, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results
por: Kennecke, Hagen F., et al.
Publicado: (2023)

Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
por: Tsang, Erica S., et al.
Publicado: (2020)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
por: Loree, Jonathan M., et al.
Publicado: (2016)

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
por: Renouf, Daniel J., et al.
Publicado: (2022)

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study
por: Chen, Eric X., et al.
Publicado: (2020)

Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs
por: Liu, Geoffrey, et al.
Publicado: (2022)

Germline Polymorphisms as Biomarkers of Tumor Response in Colorectal Cancer Patients Treated with Anti-EGFR Monoclonal Antibodies: A Systematic Review and Meta-Analysis
por: Morgen, Eric K, et al.
Publicado: (2017)

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
por: Peixoto, Renata D’Alpino, et al.
Publicado: (2015)

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
por: Topham, James T., et al.
Publicado: (2023)

Early detection of treatment futility in patients with metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2022)

Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2023)

Clustering on longitudinal quality‐of‐life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial
por: Zhang, Jiahui, et al.
Publicado: (2022)

Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions
por: Deng, Yangqing, et al.
Publicado: (2023)

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial
por: Gupta, Arjun, et al.
Publicado: (2023)

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial
por: Hoch, Jeffrey S., et al.
Publicado: (2019)

Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges
por: Vidal, Silvia, et al.
Publicado: (2019)

Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
por: Su, Alan, et al.
Publicado: (2023)

Real-world treatment attrition rates in advanced esophagogastric cancer
por: Tsang, Erica S, et al.
Publicado: (2020)

Advancing the Role of Neuroimmunity and Genetic Susceptibility in Gulf War Illness
por: Sullivan, Kimberly, et al.
Publicado: (2022)

Fc‐gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer
por: Shepshelovich, Daniel, et al.
Publicado: (2018)

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial
por: Fontana, Elisa, et al.
Publicado: (2020)

Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
por: Wong, Hui-li, et al.
Publicado: (2018)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors
por: Al-Efraij, Khalid, et al.
Publicado: (2015)

The Pathogenesis of Staphylococcus aureus Eye Infections
por: O’Callaghan, Richard J.
Publicado: (2018)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022)

The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
por: Snowdon, Jaime, et al.
Publicado: (2011)

BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development
por: Feilotter, Harriet E., et al.
Publicado: (2014)

Acetylcholinesterase inhibitor exposures as an initiating factor in the development of Gulf War Illness, a chronic neuroimmune disorder in deployed veterans
por: Michalovicz, Lindsay T., et al.
Publicado: (2020)

Supporting a Neuroimmune Basis of Gulf War Illness
por: O'Callaghan, James P., et al.
Publicado: (2016)

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies
por: Hilton, John, et al.
Publicado: (2022)

Charting the fifth force landscape
por: Banks, Hannah
Publicado: (2021)

Genomic markers of panitumumab resistance including ERBB2/HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC)
por: Barry, Garrett S., et al.
Publicado: (2016)

Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study
por: Kulke, Matthew H, et al.
Publicado: (2021)

Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT
por: Tsang, Erica S., et al.
Publicado: (2021)

A diverse and multi-modal gait dataset of indoor and outdoor walks acquired using multiple cameras and sensors
por: Topham, Luke K., et al.
Publicado: (2023)

A Projectile Concussive Impact Model Produces Neuroinflammation in Both Mild and Moderate-Severe Traumatic Brain Injury
por: Michalovicz, Lindsay T., et al.
Publicado: (2023)

Acute and lagged fitness consequences for a sagebrush obligate in a post mega‐wildfire landscape
por: Anthony, Christopher R., et al.
Publicado: (2021)

MicroRNA-146a Is Upregulated by and Negatively Regulates TLR2 Signaling
por: Quinn, Edel M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3jh8e8o1cbntjrcg5g3j9n80dl